This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Anderson B., Rashid M.H., Carter C., Pasternack G., Rajanna C., Revazishvili T., Dean T., Senecal A., Sulakvelidze A.: Enumeration of bacteriophage particles: comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assays. Bacteriophage, 1, 86–93 (2011)AndersonB.RashidM.H.CarterC.PasternackG.RajannaC.RevazishviliT.DeanT.SenecalA.SulakvelidzeA.Enumeration of bacteriophage particles: comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assaysBacteriophage18693201110.4161/bact.1.2.15456327864522334864Search in Google Scholar
API and ID32 system. https://www.biomerieux.fr/sites/subsidiary_uk/files/api-id32-identification-databases.pdf (23.01.2019)API and ID32 systemhttps://www.biomerieux.fr/sites/subsidiary_uk/files/api-id32-identification-databases.pdf (23.01.2019)Search in Google Scholar
Baeshen M.N., Al-Hejin A.M., Bora R.S., Ahmed M.M., Ramadan H.A., Saini K.S., Baeshen N.A., Redwan E.M.: Production of biopharmaceuticals in E. coli: current scenario and future perspectives. J. Microbiol. Biotechnol. 25, 953–962 (2015)BaeshenM.N.Al-HejinA.M.BoraR.S.AhmedM.M.RamadanH.A.SainiK.S.BaeshenN.A.RedwanE.M.Production of biopharmaceuticals in E. coli: current scenario and future perspectivesJ. Microbiol. Biotechnol.25953962201510.4014/jmb.1412.1207925737124Search in Google Scholar
Balding C., Balby I., Summers D. A mutational analysis of the ColE1-encoded cell cycle regulator Rcd confirms its role in plasmid stability. Plasmid, 56, 68–73 (2006)BaldingC.BalbyI.SummersD.A mutational analysis of the ColE1-encoded cell cycle regulator Rcd confirms its role in plasmid stabilityPlasmid566873200610.1016/j.plasmid.2005.12.00116442621Search in Google Scholar
BBL Crystal identification system. https://www.bd.com/en-us/offerings/capabilities/microbiology-solutions/identification-and-susceptibility-testing/bbl-crystal-identification-system (23.01. 2019)BBL Crystal identification systemhttps://www.bd.com/en-us/offerings/capabilities/microbiology-solutions/identification-and-susceptibility-testing/bbl-crystal-identification-system (23.01. 2019)Search in Google Scholar
BD Phoenix system. file:///C:/Users/Post%C4%99py%20Mikro/Downloads/DS_IDS_Phoenix-identification-taxa-sell-sheet_BR_EN%20(1).pdf (23.01.2019)BD Phoenix systemfile:///C:/Users/Post%C4%99py%20Mikro/Downloads/DS_IDS_Phoenix-identification-taxa-sell-sheet_BR_EN%20(1).pdf (23.01.2019)Search in Google Scholar
Bhopale G.M., Nanda R.K.: Recombinant DNA expression products for human therapeutic use. Curr. Sci. 89, 614–622 (2005)BhopaleG.M.NandaR.K.Recombinant DNA expression products for human therapeutic useCurr. Sci.896146222005Search in Google Scholar
Biolog ID system. https://biolog.com/products-portfolio-overview/microbial-identification/ (23.01.2019)Biolog ID systemhttps://biolog.com/products-portfolio-overview/microbial-identification/ (23.01.2019)Search in Google Scholar
Bird P., Hale G.: Cell banks and stability of antibody production. Methods Mol. Med. 40, 303–307 (2000)BirdP.HaleG.Cell banks and stability of antibody productionMethods Mol. Med.40303307200010.1385/1-59259-076-4:30321337099Search in Google Scholar
Cabrera C.M., Cobo F., Nieto A., Cortes J.L., Montes R.M., Catalina P., Concha A.: Identity tests: determination of cell line cross-contamination. Cytotechnol. 51, 45–50 (2006)CabreraC.M.CoboF.NietoA.CortesJ.L.MontesR.M.CatalinaP.ConchaA.Identity tests: determination of cell line cross-contaminationCytotechnol.514550200610.1007/s10616-006-9013-8344968319002894Search in Google Scholar
Carrier T., Donahue-Hjelle L., Stramaglia M.: Banking parental cells according to cGMP guidelines. A practical approach to developing stable cell line. BioProcess Int. 7, 20–25 (2009)CarrierT.Donahue-HjelleL.StramagliaM.Banking parental cells according to cGMP guidelines. A practical approach to developing stable cell lineBioProcess Int.720252009Search in Google Scholar
Chen R.: Bacterial expression system for recombinant protein production: E. coli and beyond. Biotechnol. Adv. 30, 1102–1107 (2012)ChenR.Bacterial expression system for recombinant protein production: E. coli and beyondBiotechnol. Adv3011021107201210.1016/j.biotechadv.2011.09.01321968145Search in Google Scholar
Chen X.A., Xu Z.N., Cen P.L.: Enhanced plasmid stability and production of hEGF by immobilized recombinant E. coli JM101. Biochem. Eng. J. 28, 215–219 (2006)ChenX.A.XuZ.N.CenP.L.Enhanced plasmid stability and production of hEGF by immobilized recombinant E. coli JM101Biochem. Eng. J.28215219200610.1016/j.bej.2005.03.005Search in Google Scholar
Conner J., Wuchterl D., Lopez M., Minshall B., Prusti B., Prusti R., Boclari D., Peterson J., Allen Ch.: The biomanufacturing of biotechnology products (w) Biotechnology Entrepreneurship, red. C. Shimasaki, Elsevier, 2014, s. 351–385ConnerJ.WuchterlD.LopezM.MinshallB.PrustiB.PrustiR.BoclariD.PetersonJ.AllenCh.The biomanufacturing of biotechnology productswBiotechnology Entrepreneurship red.ShimasakiC.Elsevier201435138510.1016/B978-0-12-404730-3.00026-9Search in Google Scholar
Demain A.L., Vaishnav P.: Production of recombinant proteins by microbes and higher organisms. Biotechnol. Adv. 27, 297–306 (2009)DemainA.L.VaishnavP.Production of recombinant proteins by microbes and higher organismsBiotechnol. Adv.27297306200910.1016/j.biotechadv.2009.01.00819500547Search in Google Scholar
Derouazi M., Toussaint B., Quenee L., Epaulard O., Guillaume M., Marleu R., Polack B.: High-yield production of secreted active proteins by the Pseudomonas aeruginosa type III secretin system. Appl. Environ. Microbiol. 74, 3601–3604 (2008)DerouaziM.ToussaintB.QueneeL.EpaulardO.GuillaumeM.MarleuR.PolackB.High-yield production of secreted active proteins by the Pseudomonas aeruginosa type III secretin systemAppl. Environ. Microbiol.7436013604200810.1128/AEM.02576-07242304218390679Search in Google Scholar
EU guidelines for Good Manufacturing Practice for medicinal products for human and veterinary use – volume 4. Annex 2 – Manufacture of biological active substances and medicinal products for human use. Ref. Ares(2012)778531 – 28/06/2012 (2012) (23.01.2019)EU guidelines for Good Manufacturing Practice for medicinal products for human and veterinary use – volume 4. Annex 2 – Manufacture of biological active substances and medicinal products for human use. Ref. Ares(2012)778531 – 28/06/20122012(23.01.2019)Search in Google Scholar
European Medicines Agency (EMA): Note for guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products. CPMP/BWP/3088/99 (2001) (23.01.2019)European Medicines Agency (EMA): Note for guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products. CPMP/BWP/3088/992001(23.01.2019)Search in Google Scholar
Farmakopea Polska XI. 5.14. Produkty lecznicze przenoszenia genu do stosowania u ludzi, 2017, s. 913–917.Farmakopea Polska XI. 5.14. Produkty lecznicze przenoszenia genu do stosowania u ludzi2017s.913917Search in Google Scholar
Ferrer-Miralles N., Domingo-Esoin J., Corchero J.L., Vazquez E., Villaverde A.: Microbial factories for recombinant pharmaceuticals. Microb. Cell Fact. 8, DOI: 10.1186/1475-2859-8-17 (2009)Ferrer-MirallesN.Domingo-EsoinJ.CorcheroJ.L.VazquezE.VillaverdeA.Microbial factories for recombinant pharmaceuticalsMicrob. Cell Fact.8DOI:10.1186/1475-2859-8-172009266980019317892Open DOISearch in Google Scholar
Fieder J., Wagner N., Grammatikos S., Hoffmann H, Kaufmann H., Otto R.T.: Use of flow-cytometric analysis to optimize cell banking strategies for production of biopharmaceuticals from mammalian cells. J. Biotechnol. 120, 111–120 (2005)FiederJ.WagnerN.GrammatikosS.HoffmannHKaufmannH.OttoR.T.Use of flow-cytometric analysis to optimize cell banking strategies for production of biopharmaceuticals from mammalian cellsJ. Biotechnol.120111120200510.1016/j.jbiotec.2005.05.02316043250Search in Google Scholar
FR-IR Biotyper. https://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/OpticalSpectrospcopy/FT-IR/HTS-XT/AN/AN406_YeastsBacteria_inFood_EN.pdf (23.01.2019)FR-IR Biotyperhttps://www.bruker.com/fileadmin/user_upload/8-PDF-Docs/OpticalSpectrospcopy/FT-IR/HTS-XT/AN/AN406_YeastsBacteria_inFood_EN.pdf (23.01.2019)Search in Google Scholar
Gopal G.J., Kumar A.: Strategies for the production of recombinant protein in Escherichia coli. Protein J. 32, 419–425 (2013)GopalG.J.KumarA.Strategies for the production of recombinant protein in Escherichia coliProtein J.32419425201310.1007/s10930-013-9502-523897421Search in Google Scholar
Healy M., Lupski J.R. i wsp.: Microbial DNA typing by automated repetitive sequence based PCR. J. Clin. Microbiol. 43, 199–207 (2005)HealyM.LupskiJ.R.i wsp.:Microbial DNA typing by automated repetitive sequence based PCRJ. Clin. Microbiol.43199207200510.1128/JCM.43.1.199-207.200554011215634972Search in Google Scholar
Hesse F., Wagner R.: Developments and improvements in the manufacturing of human therapeutics with mammalian cell substrates. Trends Biotechnol. 18, 173–180 (2000)HesseF.WagnerR.Developments and improvements in the manufacturing of human therapeutics with mammalian cell substratesTrends Biotechnol.18173180200010.1016/S0167-7799(99)01420-110740264Search in Google Scholar
ICH Q5A (R1). The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Viral safety evolution of biotechnology products derived from cell line of human or animal origin. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5A_R1/Step4/Q5A_R1__Guideline.pdf (23.01.2019)ICH Q5A (R1)The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Viral safety evolution of biotechnology products derived from cell line of human or animal originhttps://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5A_R1/Step4/Q5A_R1__Guideline.pdf (23.01.2019)Search in Google Scholar
ICH Q5B. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Quality of biotechnological products: analysis of expression construct in cell lines used for production of r-DNA derived protein products. CPMP/ICH/139/95. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5B/Step4/Q5B_Guideline.pdf (23.01.2019)ICH Q5B. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human useQuality of biotechnological products: analysis of expression construct in cell lines used for production of r-DNA derived protein products. CPMP/ICH/139/95https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5B/Step4/Q5B_Guideline.pdf (23.01.2019)Search in Google Scholar
ICH Q5D. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Derivation and characterization of cell substrate used for production of biotechnological/biological products.CPMP/ICH/294/95. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5D/Step4/Q5D_Guideline.pdf (23.01.2019)ICH Q5DThe international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Derivation and characterization of cell substrate used for production of biotechnological/biological products.CPMP/ICH/294/95https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5D/Step4/Q5D_Guideline.pdf (23.01.2019)Search in Google Scholar
ICH Q5E. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Comparability of biotechnological/biological products subject to changes in their manufacture process. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5E/Step4/Q5E_Guideline.pdf (23.01.2019)ICH Q5EThe international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Comparability of biotechnological/biological products subject to changes in their manufacture processhttps://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q5E/Step4/Q5E_Guideline.pdf (23.01.2019)Search in Google Scholar
ICH Q7. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Good manufacturing practice guide for active pharmaceutical ingredients. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q7/Step4/Q7_Guideline.pdf (23.01.2019)ICH Q7The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Good manufacturing practice guide for active pharmaceutical ingredientshttps://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q7/Step4/Q7_Guideline.pdf (23.01.2019)Search in Google Scholar
Jeffrey M., Koeller J., Zdunek J., Byrne R.: Validation of an enhanced method of bacterial ribotyping for improved efficiency and identification of stressed isolates. Pharm. Technol. 28, 156–166 (2004)JeffreyM.KoellerJ.ZdunekJ.ByrneR.Validation of an enhanced method of bacterial ribotyping for improved efficiency and identification of stressed isolatesPharm. Technol.281561662004Search in Google Scholar
Johnson I.S.: Human insulin from recombinant DNA technology. Science, 219, 632–637 (1983)JohnsonI.S.Human insulin from recombinant DNA technologyScience219632637198310.4324/9780429050329-5Search in Google Scholar
Jones D.T., Shirley M., Wu X., Keis S.: Bacteriophage infections in the industrial acetone butanol (AB) fermentation process. J. Mol. Microbiol. Biotechnol. 2, 21–26 (2000)JonesD.T.ShirleyM.WuX.KeisS.Bacteriophage infections in the industrial acetone butanol (AB) fermentation processJ. Mol. Microbiol. Biotechnol.221262000Search in Google Scholar
Jones K.L., Kim S.W., Keasling J.D.: Low-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteria. Metab. Eng. 2, 328–338 (2000)JonesK.L.KimS.W.KeaslingJ.D.Low-copy plasmids can perform as well as or better than high-copy plasmids for metabolic engineering of bacteriaMetab. Eng.2328338200010.1006/mben.2000.016111120644Search in Google Scholar
Jorgensen C.M., Casper M., Vrang A., Madsen S.M.: Recombinant protein expression in Lactococcus lactis using the P170 expression system. FEMS Microbiol. Lett. 351, 170–178 (2014)JorgensenC.M.CasperM.VrangA.MadsenS.M.Recombinant protein expression in Lactococcus lactis using the P170 expression systemFEMS Microbiol. Lett351170178201410.1111/1574-6968.1235124303789Search in Google Scholar
Joseph B.C., Pichaimuthu S., Srimeenakshi S., Murthy M., Selvakumar K., Ganesan M., Sadananda R.M.: An overview of the parameters for recombinant protein expression in Escherichia coli. J. Cell Sci. Ther. 6, DOI:10.4172/2157-7013.1000221 (2015)JosephB.C.PichaimuthuS.SrimeenakshiS.MurthyM.SelvakumarK.GanesanM.SadanandaR.M.An overview of the parameters for recombinant protein expression in Escherichia coliJ. Cell Sci. Ther.6DOI:10.4172/2157-7013.10002212015Open DOISearch in Google Scholar
Jozala A.F., Geraldes D.C., Tundisi L.L., Feitosa V.A., Breyer C.A., Cardoso S.L., Mazzola P.G., Oliveira-Nascimento L., Rangel-Yagui C.O., Magalhães P.O, Oliveira M.A., Pessoa A.J.: Biopharmaceuticals from microorganisms: from production to purification. Braz. J. Microbiol. 47, 51–63 (2016)JozalaA.F.GeraldesD.C.TundisiL.L.FeitosaV.A.BreyerC.A.CardosoS.L.MazzolaP.G.Oliveira-NascimentoL.Rangel-YaguiC.O.MagalhãesP.OOliveiraM.A.PessoaA.J.Biopharmaceuticals from microorganisms: from production to purificationBraz. J. Microbiol.475163201610.1016/j.bjm.2016.10.007515650027838289Search in Google Scholar
Kamionka M.: Engineering of therapeutic proteins production in Escherichia coli. Curr. Pharmaceutical Biotechnol. 12, 268–274 (2011)KamionkaM.Engineering of therapeutic proteins production in Escherichia coliCurr. Pharmaceutical Biotechnol.12268274201110.2174/138920111794295693317903221050165Search in Google Scholar
Kawamura F., Doi R.H: Construction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteases. J. Bacteriol. 160, 442–444 (1984)KawamuraF.DoiR.HConstruction of a Bacillus subtilis double mutant deficient in extracellular alkaline and neutral proteasesJ. Bacteriol.160442444198410.1128/jb.160.1.442-444.19842147406434524Search in Google Scholar
Kim L., Mogk A., Schumann W. A xylose-inducible Bacillus subtilis interaction vector and its application. Gene, 181, 71–76 (1996)KimL.MogkA.SchumannW.A xylose-inducible Bacillus subtilis interaction vector and its applicationGene1817176199610.1016/S0378-1119(96)00466-08973310Search in Google Scholar
Koenig G.L.: Viability of and plasmid retention in frozen recombinant Escherichia coli over time: a ten-year perspective study. Appl. Environment. Microbiol. 69, 6605–6609 (2003)KoenigG.L.Viability of and plasmid retention in frozen recombinant Escherichia coli over time: a ten-year perspective studyAppl. Environment. Microbiol.6966056609200310.1128/AEM.69.11.6605-6609.200326230814602619Search in Google Scholar
Kunji E.R., Slotboom D.J., Poolman B.: Lactococcus lactis as host for overproduction of functional membrane proteins. Biochim. Biophys. Acta, 1610, 97–108 (2003)KunjiE.R.SlotboomD.J.PoolmanB.Lactococcus lactis as host for overproduction of functional membrane proteinsBiochim. Biophys. Acta161097108200310.1016/S0005-2736(02)00712-512586384Search in Google Scholar
Lee C., Kim J., Shin S.G., Hwang S.: Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli. J. Biotechnol. 123, 273–280 (2006)LeeC.KimJ.ShinS.G.HwangS.Absolute and relative QPCR quantification of plasmid copy number in Escherichia coliJ. Biotechnol.123273280200610.1016/j.jbiotec.2005.11.01416388869Search in Google Scholar
Łoś M., Czyż A., Sell E., Węgrzyn A., Neubauer P., Węgrzyn G.: Bacteriophage contamination: is there a simply method to reduce its deleterious effects in laboratory cultures and biotechnological factories? J. Appl. Genet. 45, 111–120 (2004)ŁośM.CzyżA.SellE.WęgrzynA.NeubauerP.WęgrzynG.Bacteriophage contamination: is there a simply method to reduce its deleterious effects in laboratory cultures and biotechnological factories?J. Appl. Genet.451111202004Search in Google Scholar
Mack L., Brill B., Delis N., Groner B.: Endotoxin depletion of recombinant protein preparations through their preferential binding to histidine tags. Analytical Biochem. 466, 83–88 (2014)MackL.BrillB.DelisN.GronerB.Endotoxin depletion of recombinant protein preparations through their preferential binding to histidine tagsAnalytical Biochem.4668388201410.1016/j.ab.2014.08.02025172132Search in Google Scholar
MALDI Biotyper system. https://www.bruker.com/products/mass-spectrometry-and-separations/maldi-biotyper-for-microbiological-research.html (23.01.2019)MALDI Biotyper systemhttps://www.bruker.com/products/mass-spectrometry-and-separations/maldi-biotyper-for-microbiological-research.html (23.01.2019)Search in Google Scholar
Marco M.B., Moineau S., Quiberoni A.: Bacteriophages and dairy fermentations. Bacteriophage, 2, 149–158 (2012)MarcoM.B.MoineauS.QuiberoniA.Bacteriophages and dairy fermentationsBacteriophage2149158201210.4161/bact.21868353052423275866Search in Google Scholar
Martin M.C., Ladero V., Alvarez M.A.: PCR identification of lysogenic Lactococcus lactis strains. J. Verbrauch. Lebensm. 1, 121–124 (2006)MartinM.C.LaderoV.AlvarezM.A.PCR identification of lysogenic Lactococcus lactis strainsJ. Verbrauch. Lebensm.1121124200610.1007/s00003-006-0020-7Search in Google Scholar
Matejczyk M.: Environmental and recombinant microorganism for biopharmaceuticals production. Civ. Environment. Eng. 5, 15–21 (2014)MatejczykM.Environmental and recombinant microorganism for biopharmaceuticals productionCiv. Environment. Eng515212014Search in Google Scholar
MicroSEQ ID microbial identification scientific. https://www.thermofisher.com/order/catalog/product/A30373 (23.01.2019)MicroSEQ ID microbial identification scientifichttps://www.thermofisher.com/order/catalog/product/A30373 (23.01.2019)Search in Google Scholar
Morello E., Bermúdez-Humarán L.G., Llull D., Sole V., Miraglio N., Langella P., Poquet I.: Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J. Mol. Microbiol. Biotechnol. 14, 48–58 (2008)MorelloE.Bermúdez-HumaránL.G.LlullD.SoleV.MiraglioN.LangellaP.PoquetI.Lactococcus lactis, an efficient cell factory for recombinant protein production and secretionJ. Mol. Microbiol. Biotechnol.144858200810.1159/00010608217957110Search in Google Scholar
O’Sullivan D., Ross R.P., Fitzgerald G.F., Coffey A.: Investigation of the relationship between lysogeny and lysis of Lactococcus lactis in cheese using prophage-targeted PCR. Appl. Environ. Microbiol. 66, 2192–2198 (2000)O’SullivanD.RossR.P.FitzgeraldG.F.CoffeyA.Investigation of the relationship between lysogeny and lysis of Lactococcus lactis in cheese using prophage-targeted PCRAppl. Environ. Microbiol.6621922198200010.1128/AEM.66.5.2192-2198.200010147210788399Search in Google Scholar
Oliveira J., Mahony J., Hanemaaijer L., Thijs R.H.M., Neve H., MacSharry J., van Sinderen D.: Detecting Lactococcus lactis prophages by mitomycin C-mediated induction coupled to flow cytometry analysis.. Front Microbiol. 8, 1343 (2017)OliveiraJ.MahonyJ.HanemaaijerL.ThijsR.H.M.NeveH.MacSharryJ.van SinderenD.Detecting Lactococcus lactis prophages by mitomycin C-mediated induction coupled to flow cytometry analysis.Front Microbiol81343201710.3389/fmicb.2017.01343551585728769907Search in Google Scholar
Olson W.P., Groves M.J., Klegerman M.E.: Identification of bacterial contamination in a pharmaceutical manufacturing facility by GC FA analysis. Pharm. Technol. 14, 32–36 (1990)OlsonW.P.GrovesM.J.KlegermanM.E.Identification of bacterial contamination in a pharmaceutical manufacturing facility by GC FA analysisPharm. Technol.1432361990Search in Google Scholar
Pinevich A.V., Andronov E.E., Pershina E.V., Pinevich A.A., Dmitrieva H.Y.: Testing culture purity in prokaryotes: criteria and challenges. Antonie Van Leeuwenhoek, 111, 1509–1521 (2018)PinevichA.V.AndronovE.E.PershinaE.V.PinevichA.A.DmitrievaH.Y.Testing culture purity in prokaryotes: criteria and challengesAntonie Van Leeuwenhoek11115091521201810.1007/s10482-018-1054-429488181Search in Google Scholar
Quianzon C.C, Cheikh I.: History of insulin. J. Community Hosp. Intern. Med. Perspect. 2, DOI: 10.3402/jchimp.v2i2.18701 (2012)QuianzonC.CCheikhI.History of insulinJ. Community Hosp. Intern. Med. Perspect.2DOI:10.3402/jchimp.v2i2.187012012371406123882369Open DOISearch in Google Scholar
Rai M., Padh H.: Expression systems for production of heterologous proteins. Curr. Sci. 80, 1121–1128 (2001)RaiM.PadhH.Expression systems for production of heterologous proteinsCurr. Sci.80112111282001Search in Google Scholar
RiboPrinter system. https://www.hygiena.com/riboprinter-system-technology.html (23.01.2019)RiboPrinter systemhttps://www.hygiena.com/riboprinter-system-technology.html (23.01.2019)Search in Google Scholar
Rosano G.L., Ceccarelli E.A.: Recombinant protein expression in Escherichia coli: advance and challenges. Front. Microbiol. 5, 172, DOI: 10.3389/fmicb.2014.00172 (2014)RosanoG.L.CeccarelliE.A.Recombinant protein expression in Escherichia coli: advance and challengesFront. Microbiol.5172DOI:10.3389/fmicb.2014.001722014402900224860555Open DOISearch in Google Scholar
Rozporządzenie Ministra Zdrowia z dnia 1 października 2008 roku w sprawie Dobrej Praktyki Wytwarzania. Dziennik Ustaw Nr 184 pozycja 1143, http://prawo.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20081841143 (23.01.2019)Rozporządzenie Ministra Zdrowia z dnia 1 października 2008 roku w sprawie Dobrej Praktyki Wytwarzania. Dziennik Ustaw Nr 184 pozycja 1143http://prawo.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WDU20081841143 (23.01.2019)Search in Google Scholar
Sakhano N.G., Gunar O.V.: Microbial identification methods in pharmaceutical analysis: comparison and evaluation. M. J. Phar. 1, 001 (2016)SakhanoN.G.GunarO.V.Microbial identification methods in pharmaceutical analysis: comparison and evaluationM. J. Phar.10012016Search in Google Scholar
Sanchez-Garcia L., Martin L., Mangues R., Ferrer-Miralles N., Bazquez E., Villaverde A.: Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb. Cell Fact. 15, 33, DOI: 10.1186/s12934-016-0437-3 (2016)Sanchez-GarciaL.MartinL.ManguesR.Ferrer-MirallesN.BazquezE.VillaverdeA.Recombinant pharmaceuticals from microbial cells: a 2015 updateMicrob. Cell Fact.1533DOI:10.1186/s12934-016-0437-32016474852326861699Open DOISearch in Google Scholar
Sandle T. Automated microbial identification: a comparison of USP and EP approaches. Am. Pharm. Rev. 4, 56–61 (2013)SandleT.Automated microbial identification: a comparison of USP and EP approachesAm. Pharm. Rev456612013Search in Google Scholar
Schiff L.J.: Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products. In vivo Cell Dev. Biol. Anim. 4, 65–70 (2005)SchiffL.J.Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological productsIn vivo Cell Dev. Biol. Anim.46570200510.1290/0503024.116029074Search in Google Scholar
Sekhon B.S.: Biopharmaceuticals: an overview. Thai J. Pharm. Sci. 34, 1–19 (2010)SekhonB.S.Biopharmaceuticals: an overviewThai J. Pharm. Sci.341192010Search in Google Scholar
Seth G.: Recent advances in optimal cell banking of mammalian cells for biopharmaceutical production. Pharm. Bioprocess, 3, 35–43 (2015)SethG.Recent advances in optimal cell banking of mammalian cells for biopharmaceutical productionPharm. Bioprocess33543201510.4155/pbp.14.46Search in Google Scholar
Sherlock Microbial Identification System (MIDI). http://midi-inc.com/pages/shimadzu.html (23.01.2019)Sherlock Microbial Identification System (MIDI)http://midi-inc.com/pages/shimadzu.html (23.01.2019)Search in Google Scholar
Silva F., Queiroz J.A., Domingues F.C.: Evaluation metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli. Biotechnol. Adv. 30, 691–708 (2012)SilvaF.QueirozJ.A.DominguesF.C.Evaluation metabolic stress and plasmid stability in plasmid DNA production by Escherichia coliBiotechnol. Adv.30691708201210.1016/j.biotechadv.2011.12.00522244816Search in Google Scholar
Singhal N., Kumar M., Kanaujia P.K., Virdi J.S.: MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front. Microbiol. 6, 791 DOI: 10.3389/fmicb.2015.00791 (2015)SinghalN.KumarM.KanaujiaP.K.VirdiJ.S.MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosisFront. Microbiol.6791DOI:10.3389/fmicb.2015.007912015452537826300860Open DOISearch in Google Scholar
Sinha J., Inan M., Fanders S., Taoka S., Gouthro M., Swanson T., Barent R., Barthuli A., Loveless B.M., Smith L.A., Smith T., Henderson I., Ross J., Meagher M.M.: Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(Hc): antigen E) by Pichia pastoris. J. Biotechnol. 127, 462–474 (2007)SinhaJ.InanM.FandersS.TaokaS.GouthroM.SwansonT.BarentR.BarthuliA.LovelessB.M.SmithL.A.SmithT.HendersonI.RossJ.MeagherM.M.Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(Hc): antigen E) by Pichia pastorisJ. Biotechnol.127462474200710.1016/j.jbiotec.2006.07.02217010465Search in Google Scholar
Sorensen H.P., Mortensen K.K.: Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115, 113–128 (2005)SorensenH.P.MortensenK.K.Advanced genetic strategies for recombinant protein expression in Escherichia coliJ. Biotechnol.115113128200510.1016/j.jbiotec.2004.08.00415607230Search in Google Scholar
Summers D.K., Betton C.W, Withers H.L.: Multicopy plasmid instability: the dimer catastrophe hypothesis. Mol. Microbiol. 8, 1031–1038 (1993)SummersD.K.BettonC.WWithersH.L.Multicopy plasmid instability: the dimer catastrophe hypothesisMol. Microbiol.810311038199310.1111/j.1365-2958.1993.tb01648.x8361350Search in Google Scholar
Sutton S.: Qualification of a microbial identification system. J. Valid. Technol. 17, 50–53 (2011)SuttonS.Qualification of a microbial identification systemJ. Valid. Technol.1750532011Search in Google Scholar
Sutton A.: Product development of probiotics as biological drugs. Clin. Infect. Dis. 46, S128–132 (2008)SuttonA.Product development of probiotics as biological drugsClin. Infect. Dis.46S128132200810.1086/52332518181718Search in Google Scholar
Terpe K.: Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 72, 211–222 (2006)TerpeK.Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systemsAppl. Microbiol. Biotechnol.72211222200610.1007/s00253-006-0465-816791589Search in Google Scholar
Vitek 2 Compact system. https://www.biomerieux-usa.com/sites/subsidiary_us/files/18-vitek2-systembrochure_v2_0.pdf (23.01.2019)Vitek 2 Compact systemhttps://www.biomerieux-usa.com/sites/subsidiary_us/files/18-vitek2-systembrochure_v2_0.pdf (23.01.2019)Search in Google Scholar
Vitek MS. https://www.biomerieux-diagnostics.com/vitekrms-0 (23.01.2019)Vitek MShttps://www.biomerieux-diagnostics.com/vitekrms-0 (23.01.2019)Search in Google Scholar
Westers L., Westers H., Quax W.: Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Bioch. Biophy. Acta, 1694, 299–310 (2004)WestersL.WestersH.QuaxW.Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organismBioch. Biophy. Acta1694299310200410.1016/j.bbamcr.2004.02.01115546673Search in Google Scholar
WHO Expert Committee on Biological Standardization, 66th Report, Annex 2. WHO Press, Geneva, 2015, s. 93–130 (23.01.2019)WHO Expert Committee on Biological Standardization66th Report, Annex 2.WHO PressGeneva2015s.93130(23.01.2019)Search in Google Scholar
Xu J., Li W., Zhang Y., Zhiu Z., Liu J., Hu Z.: Stability of plasmid and expression of a recombinant gonadotropin-releasing hormone (GnRH) vaccine in Escherichia coli. Appl. Microbiol. Biotechnol. 73, 780–788 (2006)XuJ.LiW.ZhangY.ZhiuZ.LiuJ.HuZ.Stability of plasmid and expression of a recombinant gonadotropin-releasing hormone (GnRH) vaccine in Escherichia coliAppl. Microbiol. Biotechnol.73780788200610.1007/s00253-006-0547-716896597Search in Google Scholar
Zaleski P., Wawrzyniak P., Sobolewska A., Płucienniczak P.: Plazmidy jako wektory do terapii genowej. Post. Mikrobiol. 56, 214–225 (2017)ZaleskiP.WawrzyniakP.SobolewskaA.PłucienniczakP.Plazmidy jako wektory do terapii genowejPost. Mikrobiol.562142252017Search in Google Scholar
Zarnowiec P., Lechowicz Ł., Czerwonka G., Kaca W.: Fourier Transform Infrared Spectroscopy (FTIR) as a tool for the identification and differentiation of pathogenic bacteria. Curr. Med. Chem. 22, 1710–1718 (2015)ZarnowiecP.LechowiczŁ.CzerwonkaG.KacaW.Fourier Transform Infrared Spectroscopy (FTIR) as a tool for the identification and differentiation of pathogenic bacteriaCurr. Med. Chem.2217101718201510.2174/092986732266615031115280025760086Search in Google Scholar
